Wednesday, February 12, 2014

Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 17 Issue 1

If you are unable to see the message below, click here to view.
Prostate Cancer and Prostatic Disease
Advertisement
Frontiers helps you make the most of your valuable professional network through our unique research network.
Connect to colleagues, increase your impact and benefit from a 30% increase in downloads of any publication you link to your profile. 

Register today
 

TABLE OF CONTENTS

Volume 17, Issue 1 (March 2014)

In this issue
Reviews
Original Articles
Corrigendum
Erratum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement


Try the new prostate cancer crossword puzzle

What are the two glands that sit on top of the kidneys? What is the substance made by the prostate? What is the acronym referring to the stomach and the intestines? Check out the new prostate cancer crossword puzzle from PCAN. You could even win three months of free access to the site. 

Click to get started on the crossword. 
 
 

Reviews

Top

Robotic-assisted simple prostatectomy: a systematic review and report of a single institution case series

P Banapour, N Patel, C J Kane, S A Cohen and J K Parsons

Prostate Cancer Prostatic Dis 2014 17: 1-5; advance online publication, December 10, 2013; 10.1038/pcan.2013.52

Abstract | Full Text

Original Articles

Top

Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study

A Lustman, S Nakar, A D Cohen and S Vinker

Prostate Cancer Prostatic Dis 2014 17: 6-9; advance online publication, September 24, 2013; 10.1038/pcan.2013.34

Abstract | Full Text

EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer

E Kashiwagi, M Shiota, A Yokomizo, J Inokuchi, T Uchiumi and S Naito

Prostate Cancer Prostatic Dis 2014 17: 10-17; advance online publication, November 26, 2013; 10.1038/pcan.2013.53

Abstract | Full Text

Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients

T Kamigaito, T Okaneya, M Kawakubo, H Shimojo, O Nishizawa and J Nakayama

Prostate Cancer Prostatic Dis 2014 17: 18-22; advance online publication, December 24, 2013; 10.1038/pcan.2013.56

Abstract | Full Text

Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy

E M Van Allen, A Foye, N Wagle, W Kim, S L Carter, A McKenna, J P Simko, L A Garraway and P G Febbo

Prostate Cancer Prostatic Dis 2014 17: 23-27; advance online publication, December 24, 2013; 10.1038/pcan.2013.37

Abstract | Full Text

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer

C J Paller, D Olatoye, S Xie, X Zhou, S R Denmeade, M A Eisenberger, E S Antonarakis, M A Carducci and G L Rosner

Prostate Cancer Prostatic Dis 2014 17: 28-33; advance online publication, October 8, 2013; 10.1038/pcan.2013.40

Abstract | Full Text

Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer OPEN

O B Goodman, Jr, T W Flaig, A Molina, P F A Mulders, K Fizazi, H Suttmann, J Li, T Kheoh, J S de Bono and H I Scher

Prostate Cancer Prostatic Dis 2014 17: 34-39; advance online publication, October 1, 2013; 10.1038/pcan.2013.41

Abstract | Full Text

Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard

M Abd-Alazeez, A Kirkham, H U Ahmed, M Arya, E Anastasiadis, S C Charman, A Freeman and M Emberton

Prostate Cancer Prostatic Dis 2014 17: 40-46; advance online publication, October 15, 2013; 10.1038/pcan.2013.43

Abstract | Full Text

Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)

K E Bremner, N Mitsakakis, L Wilson and M D Krahn

Prostate Cancer Prostatic Dis 2014 17: 47-56; advance online publication, October 15, 2013; 10.1038/pcan.2013.44

Abstract | Full Text

Very-high-risk localized prostate cancer: definition and outcomes

D Sundi, V M Wang, P M Pierorazio, M Han, T J Bivalacqua, M W Ball, E S Antonarakis, A W Partin, E M Schaeffer and A E Ross

Prostate Cancer Prostatic Dis 2014 17: 57-63; advance online publication, November 5, 2013; 10.1038/pcan.2013.46

Abstract | Full Text

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

A E Ross, F Y Feng, M Ghadessi, N Erho, A Crisan, C Buerki, D Sundi, A P Mitra, I A Vergara, D J S Thompson, T J Triche, E Davicioni, E J Bergstralh, R B Jenkins, R J Karnes and E M Schaeffer

Prostate Cancer Prostatic Dis 2014 17: 64-69; advance online publication, October 22, 2013; 10.1038/pcan.2013.49

Abstract | Full Text

[-2]proPSA is an early marker for prostate cancer aggressiveness

I Heidegger, H Klocker, E Steiner, V Skradski, M Ladurner, R Pichler, G Schäfer, W Horninger and J Bektic

Prostate Cancer Prostatic Dis 2014 17: 70-74; advance online publication, October 29, 2013; 10.1038/pcan.2013.50

Abstract | Full Text

Anterior tumors of the prostate: clinicopathological features and outcomes

J Mygatt, I Sesterhenn, I Rosner, Y Chen, J Cullen, T Morris-Gore, J Barton, A Dobi, S Srivastava, D McLeod and S A Brassell

Prostate Cancer Prostatic Dis 2014 17: 75-80; advance online publication, December 3, 2013; 10.1038/pcan.2013.54

Abstract | Full Text

An expression signature at diagnosis to estimate prostate cancer patients’ overall survival OPEN

Z Peng, L Skoog, H Hellborg, G Jonstam, I-L Wingmo, M Hjälm-Eriksson, U Harmenberg, G C Cedermark, K Andersson, L Ährlund-Richter, S Pramana, Y Pawitan, M Nistér, S Nilsson and C Li

Prostate Cancer Prostatic Dis 2014 17: 81-90; advance online publication, January 7, 2014; 10.1038/pcan.2013.57

Abstract | Full Text

Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database

D M Moreira, M R Cooperberg, L E Howard, W J Aronson, C J Kane, M K Terris, C L Amling, M Kuchibhatla and S J Freedland

Prostate Cancer Prostatic Dis 2014 17: 91-96; advance online publication, January 14, 2014; 10.1038/pcan.2013.59

Abstract | Full Text

Corrigendum

Top

Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia

J M Devaney, S Wang, S Funda, J Long, D J Taghipour, R Tbaishat, P Furbert-Harris, M Ittmann and B Kwabi-Addo

Prostate Cancer Prostatic Dis 2014 17: 97; 10.1038/pcan.2013.58

Full Text

Erratum

Top

Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)

K E Bremner, N Mitsakakis, L Wilson and M D Krahn

Prostate Cancer Prostatic Dis 2014 17: 98-104; 10.1038/pcan.2013.55

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: